McKesson Corp. closed 6.64% below its 52-week high of $637.51, which the company achieved on August 2nd.

Evercore ISI analyst Elizabeth Anderson CFA reiterated a Buy rating on McKesson (MCK – Research Report) yesterday and set a price target of ...

Analysis of the S&P 500 health care sector's performance, quant ratings of top companies, and expert opinions on future ...

especially in specialty products and GLP-1 medications, as well as contributions from Prescription Technology Solutions and Medical-Surgical Solutions. Furthermore, McKesson raised its fiscal 2025 ...

With a market cap of $74.3 billion, Irving, Texas-based McKesson Corporation (MCK) is a global healthcare services and ...

McKesson (MCK) closed the most recent trading day at $585.08, moving +0.57% from the previous trading session. The stock exceeded the S&P 500, which registered a gain of 0.16% for the day. Meanwhile, ...

After hours: January 17 at 6:47:50 p.m. EST ...

In the fast-evolving landscape of supply chain management, 2025 presents a unique set of challenges and opportunities for executives. As companies navigate the complexities of global business ...

Medical research involves research in a wide range of fields, such as biology, chemistry, pharmacology and toxicology with the goal of developing new medicines or medical procedures or improving ...

Our guide to upcoming products provides an overview of all of the new devices that we're expecting to see in 2025, based on the most current rumors. The dates listed here are not always concrete ...

by Ishai Menache, Jeevan Pathuri, David Simchi-Levi and Tom Linton Companies face a variety of complex challenges in designing and optimizing their supply chains. Increasing their resilience ...